Chemical Name: Fructose-1,6-diphosphate
CAS No.:488-69-7
Molecular Formula: C6H14O12P2
Molecular Weight: 340.115682
Appearance: White crystalline or crystalline powder
Assay: 98%min
Chemical Name: Fructose-1,6-diphosphate
CAS No.:488-69-7
Molecular Formula: C6H14O12P2
Molecular Weight: 340.115682
Appearance: White crystalline or crystalline powder
Assay: 98%min
CAS 488-69-7Quick Details
Chemical Name: Fructose-1,6-diphosphate
CAS No.:488-69-7
Molecular Formula: C6H14O12P2
Chemical Structure:
Molecular weight: 340.115682
Appearance: White crystalline or crystalline powder
Assay: 98%min
CAS 488-69-7 Typical Properties
Item | Specifications | Results |
Appearance | White crystalline or crystalline powder | White crystalline |
Identify | ||
TLC | Must be similar in TLC spots and colour | Conforms |
Precipitation | positive reaction | positive reaction |
Sodium salt | positive reaction | positive reaction |
IR | Must be similarto parallel table | Conforms |
Inspect | ||
Granularity | 30 | Conforms |
Acidity | PH: 5.5~6.5 | 6.01 |
Appearance of solution | colorless | Conforms |
Moisture | 24.0~27.0% | 26.59% |
Heavy metal(Pb),mg/kg | ≤1.5 | Conforms |
Arsenic(As),mg/kg | ≤1.0 | Conforms |
Bacterial count,cfu/g | ≤1000 | Conforms |
Colibacillus,MPN/100g | ≤40 | Conforms |
Yeast, mold,cfu/g | ≤25 | Conforms |
Assay, Anhydrous,% | ≥98.0% | 98.92% |
What isFructose-1,6-diphosphate?
Fructose-1,6-diphosphate is a sugar metabolism intermediate existing in the human body. It regulates the activity of several enzymes in glucose metabolism, increases the concentration of intracellular adenosine triphosphate and phosphocreatine, promotes potassium influx, and increases intracellular red blood cells. The content of phosphoglycerate inhibits the release of oxygen free radicals and histamine, alleviates the tissue damage caused by ischemia and hypoxia, and has a good protective effect on the myocardium under ischemia. It is often used for myocardial ischemia and heart. Adjuvant therapy for failure. The side effects are mainly pain at the injection site, numbness of the lips, occasional dizziness, chest tightness and allergic reactions. In this patient, a severe allergic reaction occurred 1 minute after the drug administration, suggesting that clinicians should closely observe the changes of the patient’s condition when using sodium fructose diphosphate. Once an adverse reaction occurs, the drug should be discontinued immediately and the corresponding treatment should be given in time. In addition, the drug should be used with caution for allergic persons.
1. This product belongs to the cardiovascular system.
2. Fructose sodium diphosphate for injection, the indication for this product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute conditions, such as blood transfusions, surgery under extracorporeal circulation, parenteral nutrition, and in the depletion of carbonic acid in chronic conditions such as chronic alcoholism, chronic malnutrition, and chronic respiratory failure. Seal and store in a cool place (not more than 20 ° C).